Medical therapy in severe hypercortisolism.
Marques JVO, Boguszewski CL.
Best Pract Res Clin Endocrinol Metab. 2021 Mar;35(2):101487. doi: 10.1016/j.beem.2021.101487. Epub 2021 Jan 20.
Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.
Golinelli S, de Marco V, Leal RO, Barbarossa A, Aniballi C, Maietti E, Tardo AM, Galac S, Fracassi F.
J Vet Intern Med. 2021 Nov;35(6):2616-2627. doi: 10.1111/jvim.16269. Epub 2021 Oct 21.
Evaluation and Treatment of Patients With Hypercortisolism: A Review.
Miller BS, Auchus RJ.
JAMA Surg. 2020 Dec 1;155(12):1152-1159. doi: 10.1001/jamasurg.2020.3280.
Cushing's syndrome: Treatment and new therapeutic approaches.
Ferriere A, Tabarin A.
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101381. doi: 10.1016/j.beem.2020.101381. Epub 2020 Jan 30.
Recent Advances on Subclinical Hypercortisolism.
Zavatta G, Di Dalmazi G.
Endocrinol Metab Clin North Am. 2018 Jun;47(2):375-383. doi: 10.1016/j.ecl.2018.01.003. Epub 2018 Apr 9.
Update on Hypercortisolism Therapy.
Arnaldi G, Trementino L.
Front Horm Res. 2016;46:87-105. doi: 10.1159/000443869. Epub 2016 May 17.
Primary Hypercortisolism.
Bravi CA.
Urol Clin North Am. 2025 May;52(2):193-204. doi: 10.1016/j.ucl.2025.01.002. Epub 2025 Feb 26.
Cushing's Syndrome Effects on the Thyroid.
Paragliola RM, Corsello A, Papi G, Pontecorvi A, Corsello SM.
Int J Mol Sci. 2021 Mar 19;22(6):3131. doi: 10.3390/ijms22063131.
Pharmacological Treatment of Cushing's Syndrome.
Castinetti F.
Arch Med Res. 2023 Dec;54(8):102908. doi: 10.1016/j.arcmed.2023.102908. Epub 2023 Nov 15.
Treating canine Cushing's syndrome: Current options and future prospects.
Sanders K, Kooistra HS, Galac S.
Vet J. 2018 Nov;241:42-51. doi: 10.1016/j.tvjl.2018.09.014. Epub 2018 Sep 27.
